A study on Erythroxylum moonii Hochr. Leaves on its Anthelmintic activity

Pharmacoâ??Clinical Study on Erythroxylum moonii Hochr. Leaves with special reference to its Krimighna (Anthelmintic) Karma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024079

Enrollment

Registered

2020-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B820- Intestinal helminthiasis, unspecified

Interventions

Intervention1: 2.0g-3.5g of Erythroxylum moonii leaf powder according to the age of the child: Route of Administration - Oral Duration of the therapy - 14 days Frequency - Twice daily before meal Anup

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children having clinical features of Krimi roga - Vivarna, Udara shoola, Gudkandu, Aruchi, Mandagni, Panduta etc. 2. Children with Hb% >10gm/dl. 3. Children with positive stool report for intestinal worm infestation.

Exclusion criteria

Exclusion criteria: 1. Children age 10 years of either sex. 2. Children with major congenital disorders and chronic debilitating diseases. 3. Children with Hb% 4. Children with negative stool report of ova.

Design outcomes

Primary

Measure	Time frame
Relieve from HelminthiasisTimepoint: 1 Month	—

Secondary

Measure	Time frame
Prevent from HelminthiasisTimepoint: 1 Year	—

Countries

India

Contacts

Public ContactProf Rabinarayan Acharya

Institute for Post Graduate Teaching and Research in Ayurveda

drrnacharya@gmail.com9924585855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026